Sales and Marketing

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.

Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …

The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the …

Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …

The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …

Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …

David Loew will leave his position as the head of Sanofi’s vaccine division to become the Chief Executive Officer of …

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …

Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …

Gilead took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to unveil new Phase 1b …

Women and minorities, particularly African Americans, continue to be under represented in clinical trials for cardiometabolic medication, according to a …